We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
-15.11%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$96.6M
AUM Growth
-$25.4M
Cap. Flow
+$324K
Cap. Flow %
0.34%
Top 10 Hldgs %
32.65%
Holding
115
New
5
Increased
35
Reduced
28
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 54.22%
2 Technology 19.39%
3 Communication Services 8.2%
4 Consumer Staples 7.55%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$133B
$1.27M 1.32%
16,508
CDNA icon
27
CareDx
CDNA
$2.26B
$1.26M 1.3%
58,492
+800
+1% +$22.2K
ATEC icon
28
Alphatec Holdings
ATEC
$1.46B
$1.23M 1.28%
188,500
+14,000
+8% +$129K
FPAY
29
DELISTED
FlexShopper
FPAY
$1.21M 1.26%
1,347,940
+5,500
+0.4% +$6.45K
MGNI icon
30
Magnite
MGNI
$2.76B
$1.21M 1.25%
136,025
+112,500
+478% +$1.21M
PDCO
31
DELISTED
Patterson Companies, Inc.
PDCO
$1.13M 1.17%
37,200
-250
-0.7% -$7.83K
ACHV icon
32
Achieve Life Sciences
ACHV
$659M
$1.11M 1.15%
228,100
+53,500
+31% +$363K
TGT icon
33
Target
TGT
$65.6B
$1.1M 1.14%
7,779
MRK icon
34
Merck
MRK
$322B
$1.1M 1.13%
12,025
ASPU
35
DELISTED
ASPEN GROUP, INC.
ASPU
$1.07M 1.1%
1,087,375
-43,000
-4% -$41.9K
EGIO
36
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.05M 1.09%
11,375
-13
-0.1% -$1.87K
GILD icon
37
Gilead Sciences
GILD
$162B
$965K 1%
15,617
-150
-1% -$9.29K
VCEL icon
38
Vericel Corp
VCEL
$2.35B
$916K 0.95%
36,367
-1,200
-3% -$35.4K
CATX icon
39
Perspective Therapeutics
CATX
$332M
$901K 0.93%
291,450
+11,600
+4% +$35.4K
VZ icon
40
Verizon
VZ
$195B
$884K 0.92%
17,417
T icon
41
AT&T
T
$159B
$871K 0.9%
41,537
-11,207
-21% -$223K
AKTS
42
DELISTED
Akoustis Technologies Inc
AKTS
$836K 0.87%
225,950
+31,500
+16% +$140K
CIEN icon
43
Ciena
CIEN
$53.4B
$823K 0.85%
18,000
DERM icon
44
Journey Medical
DERM
$175M
$823K 0.85%
220,050
+28,300
+15% +$112K
MMM icon
45
3M
MMM
$90.9B
$816K 0.84%
7,537
-125
-2% -$15.1K
AUGX
46
DELISTED
Augmedix, Inc. Common Stock
AUGX
$791K 0.82%
439,500
+10,500
+2% +$24.3K
MDXH icon
47
MDxHealth
MDXH
$21.5M
$755K 0.78%
90,458
+458
+0.5% +$3.54K
CSTL icon
48
Castle Biosciences
CSTL
$855M
$728K 0.75%
33,170
FBIO icon
49
Fortress Biotech
FBIO
$104M
$639K 0.66%
50,733
+43,879
+640% +$650K
PLUS icon
50
ePlus
PLUS
$2.42B
$637K 0.66%
12,000

Similar funds

Perkins Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Perkins Capital Management held 115 positions worth $96.6M, down 21% from $122M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Perkins Capital Management's Q2 2022 filing shows 5 new, 35 increased, 28 reduced and 10 closed positions. Its largest new stake was American Bitcoin Corp: 72 shares worth $300K. The largest sale was Antares Pharma, Inc., an estimated $1.97M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 56% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q2 2022 buy was American Bitcoin Corp: 72 shares worth $300K.
  • Perkins Capital Management added most to Magnite in Q2 2022, an estimated $1.21M increase.
  • Perkins Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $223K.
  • Perkins Capital Management fully exited Antares Pharma, Inc. in Q2 2022, selling an estimated $1.97M.
  • Perkins Capital Management's ten largest holdings make up 33% of its $96.6M portfolio in Q2 2022.
  • Perkins Capital Management opened 5 new positions and closed 10 in Q2 2022.
  • Perkins Capital Management's portfolio value fell 21% quarter-over-quarter to $96.6M.

Based on Perkins Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.